Cargando…

Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy

BACKGROUND: Lymphopenia during radiotherapy (RT) may have an adverse effect on treatment outcome. The aim of this study is to investigate associations between lymphopenia and RT parameters in patients with advanced lung cancer. Moreover, to investigate the prognostic role of lymphopenia, blood prote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abravan, Azadeh, Eide, Hanne Astrid, Helland, Åslaug, Malinen, Eirik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063172/ https://www.ncbi.nlm.nih.gov/pubmed/32181373 http://dx.doi.org/10.1016/j.ctro.2020.02.005

Ejemplares similares

Assessment of pulmonary (18)F-FDG-PET uptake and cytokine profiles in non-small cell lung cancer patients treated with radiotherapy and erlotinib
por: Abravan, Azadeh, et al.
Publicado: (2017)

Serum cytokine profiles and metabolic tumor burden in patients with non-small cell lung cancer undergoing palliative thoracic radiation therapy
por: Eide, Hanne A., et al.
Publicado: (2018)

Risk factors for radiation induced lymphopenia in patients with breast cancer receiving adjuvant radiotherapy
por: Chen, Fang, et al.
Publicado: (2021)

Palliative extracranial radiotherapy in patients receiving immunotherapy for non-small cell lung cancer: a narrative review
por: Kępka, Lucyna
Publicado: (2022)

Severe radiation-induced lymphopenia during concurrent chemoradiotherapy for stage III non-small cell lung cancer: external validation of two prediction models
por: van Rossum, Peter S. N., et al.
Publicado: (2023)

Atezolizumab and stereotactic body radiotherapy in patients with advanced non‐small cell lung cancer: safety, clinical activity and ctDNA responses—the ComIT‐1 trial
por: Horndalsveen, Henrik, et al.
Publicado: (2022)

Dose surface maps of the heart can identify regions associated with worse survival for lung cancer patients treated with radiotherapy
por: McWilliam, Alan, et al.
Publicado: (2020)

Palliative thoracic radiotherapy dose, non-small cell lung cancer with oligometastases and prognosis
por: Ampil, Federico L., et al.
Publicado: (2011)

Palliative radiotherapy
por: Spencer, Katie, et al.
Publicado: (2018)

Non-small cell lung cancer is characterised by a distinct inflammatory signature in serum compared with chronic obstructive pulmonary disease
por: Eide, Hanne Astrid, et al.
Publicado: (2016)

Heart dose and cardiac comorbidities influence death with a cardiac cause following hypofractionated radiotherapy for lung cancer
por: Banfill, Kathryn, et al.
Publicado: (2022)

Prognosis of severe lymphopenia after postoperative radiotherapy in non-small cell lung cancer: Results of a long-term follow up study
por: Jing, Wang, et al.
Publicado: (2021)

Fractionated palliative thoracic radiotherapy in non-small cell lung cancer – futile or worth-while?
por: Støchkel Frank, Malene, et al.
Publicado: (2018)

Role of Real-World Data in Assessing Cardiac Toxicity After Lung Cancer Radiotherapy
por: Abravan, Azadeh, et al.
Publicado: (2022)

The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma—differences in histological subtypes
por: Eide, Hanne A., et al.
Publicado: (2016)

Dosimetric Predictors of Treatment-related Lymphopenia induced by Palliative Radiotherapy: Predictive Ability of Dose-volume Parameters based on Body Surface Contour
por: Saito, Tetsuo, et al.
Publicado: (2016)

Quality of Life in Patients Treated with Palliative Radiotherapy for Advanced Lung Cancer and Lung Metastases
por: Koo, Kaitlin, et al.
Publicado: (2011)

Pre-radiotherapy systemic immune inflammation index associated with overall survival in patients with advanced EGFR mutant non-small cell lung cancer receiving thoracic radiotherapy
por: Chen, Dujuan, et al.
Publicado: (2022)

The retrospective cohort study for survival rate in patients with advanced hepatocellular carcinoma receiving radiotherapy or palliative care
por: Eun, Hyuk Soo, et al.
Publicado: (2011)

Risk factors for esophagitis after hypofractionated palliative (chemo) radiotherapy for non-small cell lung cancer
por: Nieder, Carsten, et al.
Publicado: (2020)

Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer in Puerto Rico
por: Quiñones-Avila, Valerie, et al.
Publicado: (2021)

Early High-Grade Thoracic Toxicity After Palliative Radiotherapy for Non-Small Cell Lung Cancer
por: Nieder, Carsten, et al.
Publicado: (2021)

Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy
por: De, Brian, et al.
Publicado: (2021)

Chemotherapy is a risk factor of lymphopenia before adjuvant radiotherapy in breast cancer
por: Chen, Fang, et al.
Publicado: (2021)

Prognostic impact of radiotherapy-induced-lymphopenia in patients treated with breast-conservative surgery
por: Yoon, Chang Ik, et al.
Publicado: (2023)

Palliative radiotherapy for gross hematuria in patients with advanced cancer
por: Ogita, Mami, et al.
Publicado: (2021)

Palliative Radiotherapy for Symptomatic Locally Advanced Breast Cancer
por: Hoeltgen, Line, et al.
Publicado: (2023)

A narrative review of evolving roles of radiotherapy in advanced non-small cell lung cancer: from palliative care to active player
por: Zhou, Yue, et al.
Publicado: (2020)

An Update on the Quality of Life Measurements in Lung Cancer Patients Receiving Palliative Radiotherapy: A Literature Review
por: Chu, Dominic, et al.
Publicado: (2013)

Spleen Volume Variation in Patients with Locally Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemo-Radiotherapy
por: Wen, Shu Wen, et al.
Publicado: (2015)

Clinical predictors of radiation-induced lymphopenia in patients receiving chemoradiation for glioblastoma: clinical usefulness of intensity-modulated radiotherapy in the immuno-oncology era
por: Byun, Hwa Kyung, et al.
Publicado: (2019)

Neural network based ensemble model to predict radiation induced lymphopenia after concurrent chemo-radiotherapy for non-small cell lung cancer from two institutions
por: Kim, Yejin, et al.
Publicado: (2023)

Cardiac-sparing radiotherapy for locally advanced non-small cell lung cancer
por: Turtle, Louise, et al.
Publicado: (2021)

Dosimetry of the brain and hypothalamus predicting acute lymphopenia and the survival of glioma patients with postoperative radiotherapy
por: Ye, Lu‐Lu, et al.
Publicado: (2019)

A review of radiation-induced lymphopenia in patients with esophageal cancer: an immunological perspective for radiotherapy
por: Wang, Xin, et al.
Publicado: (2020)

The Evolving Practice of Palliative Radiotherapy
por: Rembielak, A., et al.
Publicado: (2020)

Quality of life measurement in cancer patients receiving palliative radiotherapy for symptomatic lung cancer: a literature review
por: Salvo, N., et al.
Publicado: (2009)

Dyspnea in Patients Receiving Radical Radiotherapy for Non-Small Cell Lung Cancer: A Prospective Study
por: Sardaro, Angela, et al.
Publicado: (2020)

Hypofractionated Radiotherapy for Palliation in Locally Advanced Head and Neck Cancer
por: Spartacus, RK, et al.
Publicado: (2017)

Radiotherapy for the Palliation of Advanced Sarcomas—The Effectiveness of Radiotherapy in Providing Symptomatic Improvement for Advanced Sarcomas in a Single Centre Cohort
por: Tween, Hannah, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4gudgimg5ij80u6c0k6563t83e